PFE Stock
Pfizer Inc.
$27.43
+0.00% today
YTD +10.1%
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
52-week range
$23.68
$31.44
Valuation
P/E (trailing)38.9
Forward P/E10.5
Price / sales2.5
Price / book1.8
EPS (12 mo)$0.70
Dividend yield5.38%
Beta0.31
Financial health last 12 months
Revenue growth+1.3%
Earnings growth-59.4%
Gross margin74.9%
Net margin+6.3%
Return on equity4.6%
Debt / equity0.70
Hover a figure for what it means.
Analyst ratings Nov 2026 · 34 analysts
Consensus: Hold
Strong buy 5Buy 8
Hold 18Sell 2
Strong sell 1
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 13 | 18 | 3 | Hold |
| Oct 2026 | 13 | 18 | 2 | Hold |
| Sep 2026 | 14 | 20 | 2 | Hold |
| Aug 2026 | 14 | 20 | 2 | Hold |
Latest news
Pfizer: Struggling To Meet Dividend Beyond 2027
SeekingAlpha · 1d ago
Pfizer's Launched and Acquired Drugs Grew 32% in Q3 — and 3 Other Reasons to Buy the Stock Before 2027
Yahoo · 1d ago
SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing Agreement
Yahoo · 1d ago
Pfizer Inc. (PFE) Rose 20% as COVID Revenue Declined: Is Its New Product Portfolio Driving a Turnaround?
Yahoo · 1d ago
What Does Eli Lilly Offer That Merck Does Not?
Yahoo · 1d ago
Pfizer near-term support and resistance levels
Yahoo · 1d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.